temasek holdings

JW Therapeutics Raises US$90 Million In Series A Funding Round

The funds will be used to further advance JW Therapeutic’s chimeric antigen receptor T-cell clinical program, develop a therapeutic pipeline and build a new commercial manufacturing facility.

Temasek Invests US$800 Million In Verily

Singapore-based Temasek will invest in Alphabet's health-focused company Verily to commercialize healthcare solutions.